**Chapter 2**

[32] Merhof D et al. Optimized data preprocessing for multivariate analysis applied to 99mTc-ECD SPECT data sets SPECT, and Doppler ultrasound: A comparative study. Korean Journal of

Urology. 2010;**51**(4):260-265

[40] Bokhari S et al. 99mTcpyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretinrelated familial and senile cardiac amyloidoses. Circulation. Cardiovascular

Imaging. 2013;**6**(2):195-201

**52**(7):1068-1072

[41] Seo Y et al. Mapping of lymphatic drainage from the prostate using filtered 99mTc-sulfur nanocolloid and SPECT/ CT. Journal of Nuclear Medicine. 2011;

[42] Djekidel M, Brown RKJ, Piert M. Benefits of hybrid SPECT/CT for 111In-oxine- and Tc-99m-

hexamethylpropylene amine oximelabeled leukocyte imaging. Clinical Nuclear Medicine. 2011;**36**(7):e50-e56

[43] Yoon JK et al. In vivo tracking of

mesenchymal stem cells in acute brain trauma model. Nuclear Medicine and

[44] Sawada T et al. Preoperative clinical radioimmunodetection of pancreatic cancer by 111In-labeled chimeric monoclonal antibody Nd2. Japanese Journal of Cancer Research. 1999;

[45] Zoghi M et al. Evaluation of 111Inlabeled GnRH-I tracer for SPECT tumor imaging. Radiochemistry. 2019;**61**(2):

[46] Gholamrezanezhad A et al. In vivo

tracking of 111In-oxine labeled mesenchymal stem cells following infusion in patients with advanced cirrhosis. Nuclear Medicine and Biology.

[47] Zhu L, Ploessl K, Kung HF. PET/SPECT imaging agents for neurodegenerative diseases. Chemical Society Reviews. 2014;**43**(19):6683-6691

111In-labeled bone marrow

Biology. 2010;**37**(3):381-388

**90**(10):1179-1186

2011;**38**(7):961-967

226-232

of Alzheimer's patients and asymptomatic controls. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 2011;**31**(1):371-383

*Medical Isotopes*

[33] Ahmadzadehfar H et al. The significance of 99mTc-MAA SPECT/CT liver perfusion imaging in treatment planning for 90Y-microsphere selective internal radiation treatment. Journal of Nuclear Medicine. 2010;**51**(8):1206-1212

[34] Kotani K et al. Diagnostic ability of 99mTc-HSA-DTPA scintigraphy in combination with SPECT/CT for gastrointestinal bleeding. Abdominal

[35] Grosser OS et al. Pharmacokinetics of 99mTc-MAA- and 99mTc-HSA-

Imaging. 2014;**39**(4):677-684

preradioembolization dosimetry: Influence on the liver–lung shunt. Journal of Nuclear Medicine. 2016;

[36] de Graaf W et al. 99mTc-

mebrofenin hepatobiliary scintigraphy with SPECT for the assessment of hepatic function and liver functional volume before partial hepatectomy. Journal of Nuclear Medicine. 2010;

[37] Santra A, Kumar R, Sharma P. Use of 99m-technetium-glucoheptonate as a tracer for brain tumor imaging: An overview of its strengths and pitfalls. Indian Journal of Nuclear Medicine: IJNM: The Official Journal of the Society of Nuclear Medicine, India. 2015;**30**(1):1-8

[38] Guo J et al. Cerebral infarction on 99mTc-MDP SPECT/CT imaging. Clinical Nuclear Medicine. 2013;**38**:925-

[39] Yoo JM et al. Diagnosing acute pyelonephritis with CT, 99mTc-DMSA

microspheres used in

**57**(6):925-927

**51**(2):229-236

927

**22**
